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Abstract  16 
Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) represent one of the main therapeutic class of 17 
molecules contaminating aquatic ecosystems worldwide. NSAIDs are commonly and extensively 18 
used for their analgesic, antipyretic and anti-inflammatory properties to cure pain and inflammation 19 
in human and veterinary therapy. After use, NSAIDs are excreted in their native form or as 20 
metabolites, entering the aquatic ecosystems. A number of monitoring surveys has detected the 21 
presence of different NSAIDs in freshwater ecosystems in the ng/L - µg/L concentration range. 22 
Although the concentrations of NSAIDs in surface waters are low, the high biological activity of 23 
these molecules may confer them a potential toxicity towards non-target aquatic organisms. The 24 
present review aims at summarizing toxicity, in terms of both acute and chronic toxicity, induced by 25 
the main NSAIDs detected in surface waters worldwide, namely acetylsalicylic acid (ASA), 26 
paracetamol (PCM), diclofenac (DCF), ibuprofen (IBU) and naproxen (NPX), both singularly and 27 
in mixture, towards freshwater invertebrates. Invertebrates play a crucial role in ecosystem 28 
functioning so that NSAIDs-induced effects may result in hazardous consequences to the whole 29 
freshwater trophic chain. Acute toxicity of NSAIDs occur only at high, unrealistic concentrations, 30 
while sub-lethal effects arise also at low, environmentally relevant concentrations of all these drugs. 31 
Thus, further studies represent a priority in order to improve the knowledge on NSAID toxicity and 32 
mechanism(s) of action in freshwater organisms and to shed light on their real ecological hazard 33 
towards freshwater communities. 34 
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1. Pharmaceuticals as emerging contaminants of freshwaters 39 
In the last two decades, pharmaceutical compounds have been identified as emerging contaminants 40 
for aquatic ecosystems. Pharmaceutical compounds are extensively and increasingly used both in 41 
human and veterinary therapy, including agriculture and aquaculture (Boxall et al., 2015). 42 
Pharmaceuticals have been designed to have a specific mode of action, targeting specific organs, 43 
metabolic pathways or receptors to modulate physiological functions, to treat a disease and to 44 
restore the health of the organism. For these reasons, pharmaceuticals play a pivotal role in our 45 
society, which commonly uses, and often abuses, a number of these molecules. For instance, in the 46 
European Union (EU) alone, it has been estimated that about 3,000 different substances are used in 47 
human therapy, including anti-inflammatory drugs, contraceptives, antibiotics, β-blockers, lipid 48 
regulators, neuroactive drugs and many others (Fent et al., 2006). After their use, pharmaceuticals 49 
are excreted unchanged or as metabolites entering the sewage. As wastewater treatment plants 50 
(WWTPs) own a limited removal efficiency for several drugs, they are discharged in WWTP 51 
effluents contributing to the contamination of surface waters and, rarely, of groundwater and 52 
drinking water (Santos et al., 2010). According to the trend of production and use, as well as their 53 
pharmacokinetic and chemico-physical properties, different pharmaceuticals are detected in aquatic 54 
ecosystems in the ng/L to mg/L concentration range worldwide (Santos et al., 2010; Al Aukidy et 55 
al., 2014; Bagnis et al., 2018; Fekadu et al., 2019). In fact, a recent comprehensive review of 56 
measured environmental concentrations (MECs) for both human and veterinary pharmaceuticals on 57 
a global scale showed that 631 different substances were found water samples worldwide (aus der 58 
Beek et al., 2016). Thus, the presence of pharmaceuticals in aquatic ecosystems represents one of 59 
the main concerns that ecotoxicology has to face (Fent et al., 2006; Santos et al., 2010; Boxall et al., 60 
2015).  61 
 62 
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2. Non-Steroidal Anti-inflammatory Drugs (NSAIDs) in freshwater ecosystems  63 
Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) represent one of the most relevant therapeutic 64 
class found in aquatic ecosystems worldwide (aus der Beek et al., 2016). NSAIDs are administered 65 
for their analgesic, antipyretic and anti-inflammatory properties to cure pain and inflammation in 66 
both human and veterinary therapy. NSAIDs inhibit the synthesis and the release of prostaglandins 67 
from arachidonic acid, acting as non-selective inhibitors of cyclooxygenase (COX) enzymes, 68 
namely cyclooxygenase-1 (COX-1) and cyclooxygenase-2 (COX-2) isoforms (Gierseet al., 1995). 69 
Different NSAIDs have been prescribed extensively or are commercialized over-the-counter 70 
worldwide. For instance, more than 70 million prescriptions are written each year in the United 71 
States, while considering the over-the-counter sale, more than 30 billion NSAID doses are 72 
consumed annually in the United States alone (Wiegand and Vernetti, 2017). Because of their huge 73 
and increasing use, coupled with their specific pharmacokinetic properties, NSAIDs reach 74 
detectable concentrations in both sewage and surface water, accounting for 15% of pharmaceuticals 75 
measured in aquatic ecosystems worldwide (Santos et al., 2010). NSAIDs and analgesics are the 76 
most frequently detected class of pharmaceuticals in the environment (Fekadu et al., 2019), as a 77 
number of monitoring surveys have reported levels of NSAIDs exceeding 1 µg/L in influent and 78 
effluents of WWTPs, while lower concentrations (in the ng/L range) have been found in surface 79 
waters (Santos et al., 2010; aus der Beek et al., 2016; Bagnis et al., 2018; Fekadu et al., 2019). 80 
Diclofenac is the most frequently detected pharmaceutical in environmental samples, while also 81 
ibuprofen and naproxen were detected nearly as often as diclofenac globally (aus der Beek et al., 82 
2016). Moreover, five NSAIDs, including acetylsalicylic acid (ASA), paracetamol (PCM), 83 
diclofenac (DCF), ibuprofen (IBU) and naproxen (NPX) are included in the list of sixteen 84 
substances that were detected in surface, drinking, and groundwater of all the five United Nations 85 
(UN) regional groups (i.e., Africa Group, Asia-Pacific Group, Eastern Europe Group, Latin 86 
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American and Caribbean States Group, and Western Europe and Others Group, which also includes 87 
North America, Australia and New Zealand), with global average concentrations ranging between 88 
0.032 and 0.922 µg/L (aus der Beek et al., 2016). Although the concentrations of NSAIDs in 89 
freshwaters can be considered as relatively low, their high biological activity may pose a serious 90 
risk towards non-target species at different levels of the ecological hierarchy, leading to dissimilar 91 
toxic effects. To date, some previous reviews or meta-analyses have summarized the occurrence, 92 
toxicity and/or environmental risk of diverse pharmaceuticals (e.g., aus der Beek et al., 2016; 93 
Bagnis et al., 2018; Fekadu et al., 2019; Ohoro et al., 2019) or a specific compound (e.g., 94 
diclofenac; Acuña et al., 2015; Lonappan et al.,  2016) in aquatic ecosystems, but none has 95 
specifically focused on the toxicity of drugs belonging to a specific class of pharmaceuticals 96 
towards freshwater invertebrates. Thus, the present review aimed at summarizing the toxicity 97 
induced by the exposure to ASA, PCM, DCF, IBU and NPX towards freshwater invertebrates. 98 
Freshwater invertebrate species globally account for approximately 2% (150,000 estimated species 99 
grouped in 17 phyla; Strayer, 2006) of an estimated 6.7 million invertebrate species (Collen et al., 100 
2012). Although individually small and inconspicuous, aquatic invertebrates play a pivotal role in 101 
ecosystem functioning, including the transfer of energy from autotrophs to higher levels of the food 102 
web and the recycling of nutrients (e.g., Pingram et al., 2014; Macadam and Stockan, 2015). 103 
Moreover, many invertebrates species are easy to be cultured and maintained under laboratory 104 
conditions, and are very sensitive to exogenous stresses, including the exposure to environmental 105 
contaminants, making them excellent model organisms in ecotoxicological surveys. A systematic 106 
literature research was performed in Google Scholar, Scopus and Web of Science databases. 107 
Literature research was focused on papers published in the 2000-2019 period of time, using for each 108 
single pharmaceutical compound different combinations of keywords dealing with their effects on 109 
freshwater invertebrates, including pharmaceutical drugs, non-steroidal anti-inflammatory drugs, 110 
freshwater, invertebrates, effects, toxicity.  111 
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3. Features of focal Non-Steroidal Anti-inflammatory Drugs (NSAIDs)  112 
Acetylsalicylic acid, diclofenac, naproxen, ibuprofen and paracetamol are the most common 113 
NSAIDs detected in aquatic environments (Fekadu et al., 2019). The main physico-chemical 114 
properties of the investigated NSAIDs are reported in Table 1. Acetylsalicylic acid (ASA; 2-115 
(acetyloxy)benzoic acid) has remained for over 90 years as  one of the most prescribed analgesics in 116 
human medical care worldwide (Katzung, 2015). ASA is commonly used to reduce pain, fever, or 117 
inflammation and after oral administration it overwhelms hepatic metabolic reactions that transform 118 
it into conjugates (e.g., glucoronides) ease to be excreted. Although as much as 80% of a single 119 
therapeutic doses of ASA is metabolized in the liver, the remaining part is excreted as unchanged 120 
parent compound, entering the sewage.  ASA was detected in sewage effluent and surface water at 121 
maximum levels of 1.5 and 3.1 µg/L (e.g., Ternes, 1998; Schulman et al., 2002) respectively, even 122 
if concentrations up to 13 μg/L (Santos et al., 2010 and references therein) and even 59.6 μg/L were 123 
detected in wastewater treatment plants from Spain (Metcalfe et al., 2003). ASA was detected in 124 
surface waters, groundwater and/or tap or drinking waters from 15 Countries worldwide, with 125 
global average and maximum measured environmental concentrations of 0.922 µg/L and 20.96 126 
µg/L, respectively (aus der Beek, 2016).   127 
Paracetamol (PCM; N-(4-hydroxyphenyl)acetamide), also known as acetaminophen, is an analgesic 128 
and antipyretic drug. Although PCM does not own a proper anti-inflammatory action, it is usually 129 
included in the NSAID therapeutic group by a toxicological point of view because its mechanism of 130 
action is similar to that of NSAIDs (Misra et al., 1990). PCM can be purchased as an over-the-131 
counter sale drug in most Countries worldwide and represents one of the most frequently detected 132 
pharmaceuticals in surface waters, wastewaters and drinking water. A recent review showed that 133 
PCM was detected in surface waters, groundwater and/or tap or drinking waters from 29 Countries 134 
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worldwide, with global average and maximum measured environmental concentrations of 0.161 135 
µg/L and 230 µg/L, respectively (aus der Beek, 2016).   136 
Diclofenac (DCF; 2-[(2,6-dichlorophenyl)amino] phenylacetic acid) is a phenylacetic acid used to 137 
reduce inflammation and pain associated with arthritis, osteoarthritis, rheumatoid arthritis, and 138 
ankylosing spondylitis (Todd and Sorkin, 1988). As DCF can be sold both as an over-the-counter 139 
sale drug and under medical prescriptions, it is one of the main drugs used worldwide and, 140 
consequently, one of the main pharmaceuticals contaminating the aquatic ecosystems. As WWTPs 141 
have a limited efficiency of removal, DCF is commonly detected at low µg/L range in WWTP 142 
effluents of Europe and North and South America (Roberts and Thomas, 2006; Gómez et al., 2007). 143 
Accordingly, DCF was commonly detected also in surface waters, in concentrations ranging 144 
between low ng/L up to low µg/L (Metcalfe et al., 2003; Bound and Voulvoulis, 2006; Gros et al., 145 
2006). Because of its occurrence in aquatic ecosystems and potential toxicity, the European Union 146 
has included DCF to the list of the Water Framework Directive (2013/39/EU) as priority molecules 147 
to be monitored in aquatic ecosystems. However, as sufficient high-quality monitoring data were 148 
obtained for DCF, the EU commission decided that this substance should be removed from the 149 
watch list (commission implementing decision 2018/840/EU). DCF was detected in surface waters, 150 
groundwater and/or tap or drinking waters from 50 Countries worldwide, with global average and 151 
maximum measured environmental concentrations of 0.032 µg/L and 18.74 µg/L, respectively (aus 152 
der Beek, 2016).   153 
Ibuprofen (IBU; ((+/-)-2-(p-isobutylphenyl) propionic acid with R and S isomers) is used to relieve 154 
the symptoms of arthritis, rheumatic disorders, pain and fever (Hayashi et al., 2008). IBU represents 155 
one of the core pharmaceuticals included in the “Essential Drug List” of the World Health 156 
Organization (WHO), and it is produced in large amounts worldwide (Heckmann et al., 2007). 157 
Because of its over-the-counter sale, large prescription volume and high excretion rate (~70-80% of 158 
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the therapeutic dose), IBU has been identified as one of the main pharmaceuticals in aquatic 159 
ecosystems. Moreover, IBU has relatively high mobility into aquatic environments, but a lower 160 
persistence in comparison with other pharmaceuticals (Buser et al., 1999). IBU was detected in 161 
moderate to high concentrations both in the effluents of WWTPs and in surface waters during 162 
surveys carried out in both Europe and North America (Metcalfe et al., 2004; Santos et al., 2010). 163 
IBU was detected in surface waters, groundwater and/or tap or drinking waters from 47 Countries 164 
worldwide, with global average and maximum measured environmental concentrations of 0.108 165 
µg/L and 303 µg/L, respectively (aus der Beek, 2016).   166 
Naproxen (NPX; (S) 6-methoxy-α-methyl-2-naphthalene acetic acid) is a prototypical member of 167 
NSAIDs, commonly used in the treatment of migraine, rheumatoid arthritis, and osteoarthritis. 168 
Naproxen is metabolized in the liver and eliminated in its unchanged form (10% of the dose) or as 169 
metabolites (60% of the dose) through the urine and feces. NPX can undergo diverse 170 
biotransformation pathways, the most important being conjugation with glucuronic acid to form 171 
naproxen-β-1-O-acyl glucuronide, as well as O-dealkylation made by CYP2C9 and CYP1A2 172 
enzymes, leading the production of 6-Odesmethylnaproxen (Huq, 2006). NXP was commonly 173 
detected in surface waters at concentrations up to 32 µg/L in Pakistan, 4.5 mg/L in Canada, 0.328 174 
mg/L in China, and 0.24 mg/L in Japan (Brun et al., 2006; Komori et al., 2013; Zhao et al., 2010). 175 
A recent review showed that NPX was detected in surface waters, groundwater and/or tap or 176 
drinking waters from 45 Countries worldwide, with global average and maximum measured 177 
environmental concentrations of 0.050 µg/L and 32 µg/L, respectively (aus der Beek, 2016).   178 
 179 
 180 
 181 
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4. Accumulation and biotransformation of NSAIDs in freshwater invertebrates 182 
The studies on accumulation of NSAIDs in freshwater invertebrates were performed on different 183 
species belonging to different taxa. NSAID residues in invertebrates were relatively higher 184 
compared with other classes of pharmaceuticals and the most frequent NSAIDs accumulated and 185 
measured in invertebrates were DCF and IBU (Miller et al., 2018). Focusing on freshwater 186 
invertebrates, some studies investigated the accumulation of NSAIDs in invertebrates from different 187 
ecosystems worldwide. Measureable concentrations of DCF (12.4 ng/g dry weight) and IBU (183 188 
ng/g dry weight) were found in Hydropsyche spp. individuals from the River Segre (Spain; Huerta 189 
et al., 2015). An in-situ study aimed at developing an analytical method to determine emerging 190 
contaminants in benthic invertebrates, namely Gammarus fossarum, Potamopyrgus antipodarum 191 
and Chironomus riparius, organisms were exposed upstream and downstream of a WWTP located 192 
on a French river that drains dense urban and industrial areas in the Southeast of France (Berlioz-193 
Barbier et al., 2014). IBU was measured in G. fossarum specimens (concentration range 60.6 - 194 
105.4 ng/g wet weight) but not in P. antipodarum specimens (< limit of quantification), while DCF 195 
was measured in C. riparius specimens (concentration range 26 – 51.5 ng/g wet weight; Berlioz-196 
Barbier et al., 2014). Diclofenac was detected in measurable concentrations in Planorbis spp. (13 197 
ng/g wet weight), Hyalella azteca (20 ng/g wet weight), Utterbackia imbecillis (15 ng/g wet weight) 198 
and Corbicula fluminea (23 ng/g wet weight) from the North Bosque River (Texas, USA; Du et al., 199 
2015). Diclofenac was accumulated in diverse mussel species from the Taihu Lake (China), 200 
including Anodonta spp. (2.45 ng/g dry weight), Bellamya spp. (3.14 ng/g dry weight), 201 
Corbiculidae (2.59 ng/g dry weight), and in Siberian prawn Exopalaemon modestus (6.7 ng/g dry 202 
weight), while IBU was measured at higher mean concentrations than DCF in tissues of Bellamya 203 
spp. (71.23 ng/g dry weight), Corbiculidae (41.6 ng/g dry weight), and in Siberian prawn  (24.96 204 
ng/g dry weight) (Xie et al., 2015). Gabricova and co-authors (2015) measured DCF in Erpobdella 205 
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octoculata specimens (19.66 ng/g wet weight) from the Zivny Stream (Czech Republic), while Ruhi 206 
et al. (2016) found DCF in Hydropsyche (9 ng/g dry weight) and IBU in Hydropsyche (182.7 dry 207 
weight) and Phagocata vitta (30.9 dry weight) from the Segre River (Spain). A study by Ikkere and 208 
coauthors (2018) investigated the presence of different NSAIDs (i.e., tolfenamic acid, meloxicam, 209 
carprofen, flunixin, diclofenac, ibuprofen, phenylbutazone, ketoprofen and mefenamic acid) in soft 210 
tissues of four freshwater mussels, namely Unio tumidus, Anodonta anatina, Anodonta cygnea and 211 
Dreissena polymorpha, from Latvian ecosystems. Only IBU was detected in half of analyzed 212 
samples in concentrations ranging between 0.52 and 109 ng/g wet weight. A recent study by Yang 213 
and co-authors (2020) investigated the levels, bioaccumulation, and trophic transfer of 45 214 
pharmaceuticals and personal care products, including some DCF and IBU, in highly urbanized 215 
rivers, namely the New Qinhuai River, the Qinhuai River and a section of the Yangtze River 216 
(China). DCF and IBU were detected in measureable concentrations in phytoplankton (DCF 217 
concentration range = 1.3 – 8.4 ng/g wet weight; IBU concentration range = 14.5 – 35.8 ng/g wet 218 
weight), zooplankton (concentration range = 2.1 – 12.4 wet weight; IBU concentration range = 20.9 219 
– 48.9 ng/g wet weight) and three invertebrate species (i.e., freshwater shrimps, mussels and snails; 220 
concentration range = 1.1 – 5.9 wet weight; IBU concentration range =  4.8 – 11.6 ng/g wet weight) 221 
from the three rivers (Yang et al., 2020).  222 
After uptake, NSAIDs can undergo biotransformation processes. Cytochrome P450 mixed function 223 
oxidase (MFO) systems play a crucial role in oxidation of drugs and xenobiotics in humans and in a 224 
number of species, including bacteria, plants, fish and aquatic invertebrates (Snyder, 2000; Rewitz 225 
et al., 2006; Gottardi et al., 2016). Different P450 gene families (CYP) have been characterized in 226 
fish and invertebrates (Stegeman and Livingstone, 1998). The CYP2 family, particularly the 227 
subfamily CYP2C9, has been identified as the responsible for NSAID biotransformation (Blanco et 228 
al., 2005; Zanger et al., 2008). Another pathway of biotransformation of carboxylate NSAIDs, such 229 
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as ASA, DCF, NPX and IBU) involves the glucuronic acid conjugation catalyzed by the uridine 230 
diphosphoglucuronosyl transferase superfamily of enzymes, resulting in acyl glucuronides 231 
(Pritchard, 1993). These compounds are reactive intermediates that can undergo acyl migration and 232 
hydrolysis and can also form adducts with nucleophilic amino acid residues (Pritchard, 1993). 233 
Many NSAID-derived acyl glucuronides, including those obtained from DCF and IBU, have been 234 
shown to form covalent bonds with intra and extracellular proteins, with toxicological consequences 235 
(Boelsterli, 2007). Information on biotransformation products is currently limited to surface waters 236 
and biota. In detail, they have been scarcely determined across invertebrates, with only 12 reported 237 
concentrations (Miller et al., 2018). However, to date none of such studies included NSAIDs. Thus, 238 
developing new methods to measure biotransformation products in invertebrates represents a 239 
priority in NSAID ecotoxicology. The measurement of accumulated levels of NSAIDs and their 240 
biotransformation products in organisms should allow to perform a more reliable risk assessment 241 
for these compounds in the environment and to address prioritization of hazardous compounds, as 242 
well as to study potential pharmacological or toxicological effects for the understanding of the risk. 243 
In fact, the quantification of NSAIDs associated with effect-based studies should allow to shed light 244 
on the cause-effect relationship and threshold associated with the onset of the effect, avoiding 245 
extrapolation of exposure concentrations to observed effects (Miller et al., 2018). 246 
 247 
5. Toxicity of NSAIDs towards freshwater invertebrates 248 
Toxic effects induced by the exposure to the main NSAIDs measured in freshwater ecosystems, 249 
namely acetylsalicylic acid, paracetamol, diclofenac, ibuprofen and naproxen, in freshwater 250 
invertebrates were performed on different model species belonging to different taxa (Figure 1). The 251 
number of studies investigating NSAID chronic toxicity were higher than those focused of acute 252 
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toxicity. Crustaceans, mainly the Cladoceran Daphnia magna, were the main model organisms used 253 
to explore both acute and chronic toxicity of NSAIDs, followed by Mollusca. In Table 2-7 are 254 
summarized the studies investigating the acute or chronic toxicity of selected NSAIDs and mixtures 255 
towards freshwater invertebrates. Acute toxicity describes the effects induced by either a single 256 
exposure or multiple exposures in a short time period and appears as lethal endpoints (e.g., 257 
mortality or immobilization). Chronic toxicity describes the onset of adverse effects resulting from 258 
prolonged and repeated exposure to stressors, which appears as sub-lethal endpoints (e.g., growth 259 
inhibition, molecular or biochemical alterations, behavioral changes). 260 
5.1. Toxic effects induced by acetylsalicylic acid (ASA) 261 
The toxicity of acetylsalicylic acid (ASA) was investigated on two crustacean species (Daphnia 262 
magna and Daphnia longispina) and a planarian species (Dugesia japonica) (Table 1). Acute and 263 
chronic toxicity of ASA was investigated on Daphnia magna and Daphnia longispina through the 264 
assessment of survival (i.e., immobilization or mortality) or reproduction and growth (Marques et 265 
al., 2004a). After 48 hrs of exposure, the 50% Effect Concentration (EC50) of ASA for D. 266 
longispina was 647.31 mg/L and it was about half compared to that calculated for D. magna 267 
(1,293.05 mg/L). These results were different from those found by other studies of D. magna, 268 
showing that the 50% Lethal Concentration (LC50) at 48 hrs of ASA was 88.33 mg/L (Gómez-269 
Oliván et al., 2014) and the EC50 at 48 hrs was 88.1 mg/L (Cleuvers, 2004). Increasing 270 
concentrations of ASA significantly affected the fecundity of D. magna and D. longispina. Similar 271 
No Observed Effect Concentration (NOEC) and Lowest Observed Effect Concentration (LOEC) for 272 
both the Cladoceran species  (i.e., NOEC = 1.00 mg/L and LOEC = 1.80 mg/L) were found 273 
(Marques et al., 2004a). Considering the population intrinsic growth rate (r), ASA boosted the 274 
population growth in D. longispina, whereas an opposite trend was observed for D. magna 275 
(Marques et al., 2004a). Sub-lethal effects were induced by the exposure to 17.9 mg/L of ASA in 276 
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terms of defects in eye regeneration, unstimulated behavior, and scrunching in regenerating tails, 277 
but not in full worms, in the freshwater planarian D. japonica, suggesting developmental injuries 278 
(Zhang et al., 2019).  279 
Chronic toxicity of ASA was also investigated at biochemical level by the application of a battery 280 
of different biomarkers of oxidative stress and genotoxicity, namely lipid peroxidation, protein 281 
carbonyl content, activity of the antioxidant enzymes superoxide dismutase, catalase and 282 
glutathione peroxidase and DNA fragmentation (Gómez-Oliván et al., 2014). The exposure to a 283 
single concentration (8.8 mg/L) of ASA, corresponding to equal to the Lowest Observed Adverse 284 
Effect Level (LOAEL) obtained from a previous acute assay, induced the modulation of the activity 285 
of antioxidant enzymes, as well as the increase of lipid peroxidation and DNA fragmentation in 286 
treated specimens compared to controls (Gómez-Oliván et al., 2014). 287 
5.2 Toxic effects induced by paracetamol (PCM) 288 
The toxicity of paracetamol (PCM) was assessed on diverse freshwater invertebrate species, 289 
including a cnidarian (Hydra vulgaris) and a rotifer (Plationus patulus) species, different crustacean 290 
(Daphnia magna, Daphnia longispina and Moina macrocopa) and bivalve (Dreissena polymorpha 291 
and Corbicula fluminea) species, as well as a planarian species (Dugesia japonica) (Table 2). 292 
PCM median lethal concentrations (LC50) for D. magna was 224, 40.0, 8.06  and 5.32 mg/L at 24, 293 
48, 96 hrs and 21 days, respectively (Du et al., 2016). In the same species, the PCM median effect 294 
concentrations (EC50) for body length, number of carapaces per adult, number of broods per female 295 
and egg production per female was 4.78, 4.21, 2.38 and 1.12 mg/L, respectively (Du et al., 2016). A 296 
study performed by Nunes and coauthors (2014) investigated the toxicity of PCM towards different 297 
freshwater species, including D. magna and D. longispina. PCM toxicity was widely variable 298 
among species, even among species that were phylogenetically related. Considering acute toxicity 299 
in terms of EC50 for invertebrates, D. magna (4.7 mg/L) was more sensitive than D. longispina 300 
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(67.9 mg/L). Moreover, PCM caused mortality during a chronic toxicity reproduction test with D. 301 
magna at the highest tested concentrations (between 1.2 and 1.7 mg/L). Although treated specimens 302 
generated offspring, they did not survive over the whole duration of the experiment. A different 303 
response was observed for D. longispina, which showed a significant delay in the first reproductive 304 
event and a reduction in the fecundity, but no mortality. A study by Sarma and coauthors (2014) 305 
exposed the rotifer Plationus patulus and the cladoceran Moina macrocopa to increasing 306 
concentrations of PCM (concentration range 2 - 32 mg/L) in order to assess changes in population 307 
growth. Population growth curves of both the species were affected by PCM concentrations, 308 
showing a decrease in organism density with increasing levels of the drug. Moreover, the daily rate 309 
of population growth was negatively affected by PCM exposure in both the zooplanktonic species. 310 
A 7-days exposure to increasing PCM concentrations (concentration range 0.01 - 10 mg/L) did not 311 
affect the survival of Hydra vulgaris specimens at concentrations up to 1.0 mg/L, while no adverse 312 
effects on feeding and bud formation were induced after 17 days of exposure to the same 313 
concentration range. Moreover, the ability of dissected polyps to regenerate hypostome, tentacles 314 
and foot was not altered (Pascoe et al., 2003). All the studies mentioned above showed that acute 315 
effects of PCM occur only at mg/L concentrations, while sub-lethal effects arise also at lower, often 316 
environmentally relevant, concentrations. A decreased unstimulated speed in day 12 regenerating 317 
tails was observed in D. japonica specimens exposed to 15.5 mg/L of PCM (Zhang et al., 2019).  318 
Chronic toxicity of PCM was also investigated at low levels of the biological organization. 319 
Biochemical effects of PCM exposure were investigated in the freshwater clam Corbicula fluminea 320 
following short- (96-hrs) and long-term (28-days) exposures to increasing PCM concentrations 321 
(Brandão et al., 2014). No mortality was observed in clams over short- or long-term exposures. 322 
PCM did not modulate catalase activity but induced a significant decrease of glutathione S-323 
transferase (GST) and glutathione reductase (GR) activity over both short- and long-term 324 
exposures. A significant increase of lipid peroxidation was noted at the end of short- and long-term 325 
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exposure to the highest PCM tested concentrations. These results indicated that the exposure to 326 
increasing PCM concentration caused notable changes in the cellular redox status of C. fluminea 327 
(Brandão et al., 2014). The in-vitro cytogenotoxicity of PCM was investigated through the 328 
application of a battery of four biomarkers (i.e., the comet test to investigate DNA fragmentation 329 
and frequency of apoptotic and necrotic cells, and the neutral red retention assay - NRRA) on 330 
hemocytes collected from the zebra mussel Dreissena polymorpha exposed for 1 hour to 30, 150 331 
and 450 µg/L (Parolini et al., 2009). Dose-dependent decrease in the stability of lysosome 332 
membranes (NRRA), coupled with a significant increase in both primary (DNA fragmentation) and 333 
fixed (frequency of apoptotic and necrotic cells) genetic damage was induced by PCM. In-vivo 96-334 
hrs exposures of D. polymorpha specimens to three, environmentally relevant PCM concentrations 335 
(0.154; 0.75 and 1.51 µg/L) showed that this drug can alter the oxidative status of this bivalve 336 
species (Parolini et al., 2010). Low PCM concentrations did not cause neither mortality of zebra 337 
mussel over the duration of the experiment nor changes in hemocyte viability. Although PCM did 338 
not induce primary genetic injuries in zebra mussel hemocytes at all the tested concentration, a 339 
significant increase of fixed genetic damage, in terms of both micronuclei and apoptotic frequency, 340 
was noted at the end of the exposure to the highest tested concentrations. Moreover, a significant 341 
destabilization of lysosomal membranes and significant modulation of catalase, glutathione 342 
peroxidase (GPx) and GST activity was induced by the exposure to 0.75 and 1.51 µg/L of PCM.  343 
5.3. Toxic effects induced by Diclofenac (DCF) 344 
Acute and chronic toxicity of diclofenac (DCF) towards freshwater invertebrates was explored on a 345 
rotifer (Plationus patulus), two crustaceans (Daphnia magna and Moina macrocopa), a chironomid  346 
(Chironomus riparius), a bivalve (Dreissena polymorpha) and a gastropod (Lymnea stagnalis) 347 
species (Table 3). 348 
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Mortality of D. magna specimens arose after only 24 hrs of exposure to a high DCF concentration 349 
(486 mg/L). DFC exposure caused 50% mortality (EC50) in D. magna after 21 days of exposure to 350 
2.00 mg/L and a significant reduction of egg production at the lowest exposure concentrations of 351 
0.50 mg/L (Du et al., 2016). A study by de Oliveira and coauthors (2016) calculated that the EC50 352 
for D. magna was 123.3 mg/L, but no effects on population growth was noted after the exposure to 353 
a range of increasing DCF concentrations (concentration range 29.5 - 75 mg/L). A 21-days 354 
exposure to four increasing DCF concentrations (concentration range 5 - 5,000 µg/L) did not cause 355 
significant changes in molting frequency, number of eggs produced in the first brood, total number 356 
of eggs per individual, total number of broods per individual, body length and growth rate in D. 357 
magna specimens (Liu et al., 2017). In the same study, 96-hrs exposure to 50 µg/L of DCF induced 358 
significant changes in the expression of some genes related to detoxification, growth, development 359 
and reproduction, which were inhibited after 24 hrs and overexpressed after 48 hrs of exposure (Liu 360 
et al., 2017). In contrast, the exposure to increasing concentrations of DCF (concentration range 2 - 361 
32 mg/L) affected the population growth curves of the rotifer Plationus patulus and the cladoceran 362 
Moina macrocopa, leading to a decrease in organism density with increasing levels of drug and 363 
negative effects on the daily rate of population increase (Sarma et al., 2014).  364 
Chronic toxicity of DCF was investigated also at molecular and biochemical level in different 365 
invertebrate species. A research by Haap and co-authors (2008) investigated the toxicity of DCF at 366 
biochemical level in D. magna by assessing the modulation of heat shock protein 70 (hsp70) level 367 
as a biomarker for proteotoxicity, showing that the modulation of such protein occurred only at 368 
concentrations of DCF higher than 40 mg/L. The cyto-genotoxicity of DCF was investigated 369 
through an in-vitro approach by exposing for 1 hour hemocytes collected from the zebra mussel D. 370 
polymorpha to 60, 126 and 250 µg/L (Parolini et al., 2009). A significant cytotoxic effect, in terms 371 
of destabilization of the lysosomal membranes, was noted only after the exposure to 250 µg/L of 372 
DCF, while both primary genetic lesions (i.e., DNA fragmentation) and fixed damage to DNA (i.e., 373 
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frequency of apoptotic and necrotic cells) occurred after the exposures to all the tested 374 
concentrations. A further in-vitro experiment (Parolini et al., 2011a) investigated the toxicity of 375 
increasing DCF concentrations (0.001, 0.01, 0.1, 1 and 10 mg/L) on three different cell typologies 376 
of the zebra mussel, namely hemocytes, gill and digestive gland cells. After 96 hrs of exposure, the 377 
viability of DCF treated gill cells was significantly reduced already at the lowest tested 378 
concentration. Moreover, the viability of DCF-treated digestive gland cells was significantly 379 
reduced already after 48 hours exposure to 0.01 mg/L, while hemocyte viability was reduced 380 
already at the lowest concentration (0.001 mg/L). An in-vivo 96-hrs exposure of the zebra mussels 381 
to three increasing concentrations (95, 318 and 637 ng/L) of DCF showed a negligible cyto-382 
genotoxicity. In fact, only a slight decrease of lysosomal membrane stability was observed at the 383 
end of exposure to the highest tested concentration (637 ng/L), while no other effects arose (Parolini 384 
et al., 2011b). DCF sub-lethal toxicity in terms of immunotoxicity was assessed on the gastropod 385 
Lymnaea stagnalis exposing specimens for 3 days to environmentally relevant (concentration range 386 
1 – 10 μg/L) and therapeutic concentrations (concentration range 100 – 1,000 μg/L) of DCF 387 
(Boisseaux et al., 2017). Diclofenac induced immune responses, while no immunosuppression was 388 
observed. DCF significantly affected the immunocapacity and the immunoefficiency of the snails’ 389 
hemocytes. This effect is typical of an inflammatory response, confirmed by the increase of the 390 
NADPH-oxidase activity, mainly at  1,000 μg/L. A 10-days chronic toxicity test with C. riparius 391 
was performed to assess effects on survival, growth and developmental stage, in terms of biomass, 392 
as well as emergence rates and sex ratio after 21 days of exposure to DCF-spiked sediments. No 393 
effects on survival and no change in the sex-ratio was induced by DCF exposure. In contrast, DCF 394 
decreased the emergence ratio in organisms exposed at concentrations of 34.0 μg/g of DCF (Nieto 395 
et al., 2017). 396 
5.4. Toxic effects induced by Ibuprofen (IBU) 397 
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Acute and chronic toxicity of ibuprofen (IBU) towards freshwater invertebrates was investigated on 398 
a crustacean (Daphnia magna), a cnidarian (Hydra vulgaris), two bivalve (Dreissena polymorpha 399 
and Corbicula fluminea) and a gastropod (Planorbis carinatus) species (Table 4). 400 
Mortality of all D. magna specimens was caused after 24 hrs of exposure to high levels of IBU (200 401 
mg/L), while EC50 was calculated as 3.97 (Du et al., 2016). The 48 hrs EC50 for immobilization was 402 
estimated as 108 mg/L, while the reproduction was reduced above 10 mg/L and that survival was 403 
unaffected at concentrations up to 40 mg/L, with no survival above 80 mg/L (Heckmann et al., 404 
2005). A further study revealed that a 14-days exposure of D. magna to increasing IBU 405 
concentrations affected life-history traits and population performance of the species (Heckmann et 406 
al., 2007). Population growth rate significantly decreased at all the IBU tested concentrations, while 407 
survival was affected only at the end of the exposure to 80 mg/L of IBU. In contrast, reproductive 408 
effort was affected also by the exposure to the lowest IBU tested concentrations, whereby the 14-409 
days EC50 was calculated as 13.4 mg/L, while it was completely inhibited at 80 mg/L. Similar 410 
results were obtained by Hayashi and coauthors (2008), who exposed 5-days old D. magna 411 
specimens to the same range of IBU concentrations tested by Heckmann and coauthors (2007) for 412 
10 days. Specimens exposed to 40 mg/L of IBU generated significantly fewer offspring than 413 
controls, while no reproduction occurred at 80 mg/L. Moreover, a significant delay of the first 414 
reproductive event occurred at all the tested IBU concentrations. Daphnia magna survival was 415 
affected after the exposure to 80 mg/L during the 10-day exposure, while the population grew after 416 
the exposure to control, 20 and 40 mg/L of IBU. In contrast, a significant decrease of population 417 
growth was noted at the end of the exposure to 80 mg/L of IBU (Hayashi et al., 2008). A 7-days 418 
exposure to increasing IBU concentration did not affect the survival of the cnidarian H. vulgaris at 419 
concentrations up to 1 mg/L, while after 17 days of IBU administration neither feeding nor bud 420 
formation nor ability of dissected polyps to regenerate a hypostome, tentacles and foot were 421 
affected (Pascoe et al., 2003). However, another study showed that the exposure to 5 mg/L of IBU 422 
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inhibited the regeneration of the cnidarian, with a 96-hrs IC50 (i.e., the concentration that inhibits 423 
50% of the embryos to develop) was calculated as 3.84 mg/L (Quinn et al., 2008). Acute and sub-424 
lethal effects of IBU were also investigated on the freshwater Keeled rams horn snails (Planorbis 425 
carinatus) exposed for 72-hrs or 21-days to different IBU concentrations. The 48- and 72-hrs LC50 426 
were 17.1 mg/L at both the time points, while the 21-days LOEC and NOEC based on the survival 427 
of specimens were calculated as 45.36 and 5.36 mg/L, respectively. In addition, the 21-days LOEC 428 
and NOEC calculated for snail reproduction (i.e., hatching success) were 5.36 and 2.43 mg/L, 429 
respectively, while for growth were 2.43 and 1.02 mg/L, respectively (Pounds et al., 2008).  430 
Chronic toxicity of IBU was investigated also at molecular and biochemical level through the 431 
application of different techniques. A study by Wang and coauthors (2016) investigated the 432 
modulation of the expression of CYP360A, CYP314, and GST genes involved in the detoxification 433 
process and the responses of their associated enzymes activity, as well as in some physiological 434 
parameters (e.g., growth and reproduction) in D. magna specimens exposed to three 435 
environmentally relevant concentrations of IBU. The exposure to IBU did not affect the 436 
reproduction of cladocerans, in terms of total amount of eggs produced and total number of clutches 437 
per female, as well as of body length of treated specimens. The same experiment showed that the 438 
treatment with 0.5 μg/L of IBU inhibited the expression of CYP360A gene, while at 50 µg/L an 439 
overexpression of such gene occurred. A similar trend was also induced by the exposure to at 0.5 440 
μg/L of IBU towards the GST gene, while CYP314 expression was inhibited after a short time 441 
exposure (6 hrs), while was overexpressed after prolonged exposure time (48 hrs). Similarly, 442 
erythromycin N-demethylase  and aminopyrine N-demethylase were both inhibited after 6-hrs 443 
exposure but overexpressed after 48-hrs exposure to 0.5 μg/L. Moreover, an induction of 444 
glutathione S-transferase (GST), superoxide dismutase (SOD), and catalase (CAT) activity was 445 
observed in short-term exposure to IBU, while a dose-dependent increase of EROD activity and 446 
methane dicarboxylic aldehyde (MDA) content occurred (Wang et al., 2016). The cyto-genotoxicity 447 
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of IBU was investigated through an in-vitro approach by 1-h exposure of zebra mussel hemocytes 448 
to different IBU concentrations (Parolini et al., 2009). The stability of lysosomal membranes was 449 
reduced at the endo of the exposure to 450 and 909 µg/L of IBU, while genotoxicity, in terms of 450 
DNA fragmentation and frequency of apoptotic cells, occurred in response to all the tested 451 
concentrations. A further 96-hrs in-vivo exposure of the zebra mussel showed that IBU induced a 452 
slight cyto-genotoxicity on hemocytes at 0.2 µg/L of IBU, while higher concentrations (2 and 8 453 
µg/L) significantly affected lysosomal membrane stability and arose both primary and fixed genetic 454 
damage. In addition, IBU modulated the activity of antioxidant and detoxifying enzymes at all the 455 
tested concentrations, suggesting that this drug can imbalance the oxidative status of mussels and 456 
provoke the onset of oxidative stress also at low, environmental concentrations (Parolini et al., 457 
2011c). Similar results were obtained on the clam Corbicula fluminea (Aguirre-Martínez et al., 458 
2015). IBU induced a destabilization of lysosomal membrane at all the tested concentrations, as 459 
well as the increase of the activity of phase I and II enzymes, including the activation of GR and 460 
GPx at the highest tested concentration (50 mg/L). Moreover, an increase of lipid peroxidation, but 461 
not of DNA damage was observed at the end of the exposure to 50 µg/L (Aguirre-Martínez et al., 462 
2015). Another study performed on the zebra mussel investigated the effects of 7-days exposure to 463 
IBU at molecular level, exploring the changes in the expression of mRNA of enzymes and other 464 
proteins involved in the prevention of protein damage (hsp70) and oxidative stress (SOD, CAT and 465 
metallothionein), in the biotransformation (GST, aryl hydrocarbon receptor) and elimination (P-466 
glycoprotein) of xenobiotics, as well as in reversible protein post-translational modification (protein 467 
phosphatase 2A). Zebra mussel specimens exposed to the lowest tested concentration of IBU 468 
experienced an oxidative stress situation as pointed out by the induction of mRNA levels observed 469 
for SOD, CAT and metallothionein in in the digestive gland after 1 or 4 days of treatment. At the 470 
higher concentrations, an increase in levels of transcripts for GST occurred, suggesting the 471 
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activation of biotransformation processes of IBU or by-products deriving from oxidative stress 472 
(Contardo-Jara et al., 2011).  473 
5.5 Toxic effects induced by Naproxen (NPX) 474 
Acute and chronic toxicity induced by naproxen (NPX) towards freshwater invertebrates was 475 
investigated on a rotifer (Brachionus calyciflorus), four crustacean (Thamnocephalus platyurus, 476 
Ceriodaphnia dubia, Daphnia magna, Hyalella azteca), a cnidarian (Hydra magnipapillata) and a 477 
bivalve (Elliptio complanata) species (Table 5). Acute and chronic toxicity of NPX was assessed 478 
through standard bioassays using rotifers (Brachionus calyciflorus) and crustaceans 479 
(Thamnocephalus platyurus, Ceriodaphnia dubia). Naproxen acute toxicity for T. platyurus and B. 480 
calyciflorus (LC50; mortality) was calculated as 62.48 mg/L and 84.09 mg/L, respectively, while for 481 
C. dubia (EC50; immobilization) was 66.37 mg/L (Isidori et al., 2005). Other studies showed that 482 
acute toxicity of NPX, in terms of immobilization EC50 to crustaceans, were in the same order of 483 
magnitude (Cleuvers, 2004; Gheorghe et al., 2016; Kwak et al., 2018). The study by Isidori and 484 
coauthors (2005) showed that chronic tests were responsive at lower concentrations compared to 485 
acute ones. Chronic toxicity in terms of inhibition or population growth for rotifers and crustaceans 486 
(EC50) was 0.56 (0.40–0.62) mg/L for T. platyurus and 0.33 (0.11–0.63) mg/L for C. dubia, 487 
respectively. Similar results were obtained by Kwak and coauthors (2018) on D. magna and M. 488 
macrocopa.  489 
Sub-lethal effects of NPX were also focused on effects at molecular and biochemical levels. The 490 
exposure to NPX and its photoproducts din not induce genotoxicity neither in E. coli nor in S. 491 
typhimurium (Isidori et al., 2005). Immunotoxic effects of NPX, in terms of phagocytosis, 492 
intracellular esterase activity, adherence to microplate wells and lipid peroxidation, was tested on 493 
hemolymph collected from the freshwater mussel Elliptio complanata exposed in vitro to 2.5-100 494 
22 
 
µM (concentration range 0.57 – 23 mg/L) of NPX. Threshold effect level for phagocytosis, 495 
intracellular esterase activity and adherence to microplate wells was 35, 152 and 4 µM of NPX, 496 
respectively, while a significant decrease in lipid peroxidation occurred (Gagné et al., 2006). A 497 
study of the amphipod Hyalella azteca investigating the onset of oxidative stress and the subsequent 498 
oxidative damage to genetic material induced by NPX sodium enriched sediments showed that 48 499 
hrs of exposure to sediments enriched with 76.6 and 339.2 mg/kg of NPX induced a dose-dependent 500 
increase of genotoxicity, lipid peroxidation and protein carbonylation, as well as an increase of 501 
SOD and CAT activity coupled with a decrease of GPx activity (García-Medina et al., 2015). 502 
Similar effects were found in D. magna exposed to 0.017 mg/L of NAP that showed a significant 503 
increase of SOD and CAT activity and lipid peroxidation, while a decrease was noted for GPx. 504 
Moreover, a significant increase of genetic damage (i.e., DNA fragmentation) was noted after 48 505 
and 96 hrs of exposure to NAP (Gómez-Oliván et al., 2014). Lastly, a recent work by Yamindago 506 
and coauthors (2019) showed that NPX median lethal concentrations (LC50) in H. magnipapillata 507 
was 51.99 mg/L, 44.93 mg/L, and 42.50 mg/L after 24, 48, and 72 hrs of exposure, respectively. 508 
Morphological observation of the exposed cnidarian showed that 40 mg/L of NPX stimulated the 509 
contraction of body column and tentacles after 24 hrs. A KEGG pathway analysis of the genes 510 
differentially expressed in H. magnipapillata after NPX exposure for 6, 24, or 48 hrs pointed out 511 
various cellular and metabolic effects, including protein processing in the endoplasmic reticulum, 512 
Wnt signaling, and tryptophan metabolism (Yamindago et al., 2019). 513 
5.6 Toxic effects induced by mixtures of NSAIDs 514 
Acute and chronic toxicity induced by mixtures of NSAIDs towards freshwater invertebrates was 515 
investigated on two crustaceans (Daphnia magna and Hyalella azteca) and a bivalve species 516 
(Dreissena polymorpha) only (Table 6). A study of Cleuvers (2004) investigated the ecotoxicity of 517 
four NSAIDs, namely DCF, IBU, NPX and ASA, on D. magna. Toxicities of single NSAIDs were 518 
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relatively low, with half-maximal EC50 values in Daphnia magna ranging from 68 to 166 mg/L. 519 
The toxicity of the mixture composed by the four NSAIDs at different concentrations (EC5/4, 520 
EC10/4, EC20/4, EC50/4, and EC80/4) was considerable, even at concentrations that caused no or 521 
slight effects when the organism were exposed to the single substances. Parolini and Binelli (2012) 522 
investigated the sub-lethal effects induced by a mixture of three common NSAIDs, namely 523 
diclofenac, ibuprofen and paracetamol, on the freshwater bivalve zebra mussel (Dreissena 524 
polymorpha). Zebra mussels were exposed to three mixtures in which each single drug was 525 
included at the median value of surface waters (Low), wastewater effluents (Mid) and predicted 526 
environmental concentration (PEC; High), similar to those previously tested in experiments 527 
assessing the toxicity of each single molecule independently (Parolini et al., 2010; 2011b,c; 2013). 528 
The exposure to the three mixtures induced a significant cellular stress in bivalves, in terms of 529 
destabilization of the lysosome membranes (i.e., NRRA) probably caused by the alteration of the 530 
oxidative status of the bivalves, as indicated by the modulation of the antioxidant enzyme activity. 531 
Moreover, the mixtures induced significant increase of both primary (i.e., DNA fragmentation) and 532 
fixed (i.e., apoptosis and micronuclei) genetic damage. The effects induced by the mixture resulted 533 
higher than those observed in previous studies when the single drugs were tested individually at 534 
concentrations similar to those included in the mixtures (Parolini et al., 2010; 2011b,c). Another 535 
study investigating the toxicity of binary mixtures of DCF with PCM, IBU, NPX, and ASA 536 
compared to that of tthe same NSAIDs in their isolated form, on the amphipod Hyalella azteca 537 
showed that NSAIDs induced oxidative stress both in isolated form and in binary mixtures (Gómez-538 
Oliván et al., 2014). In detail, modulation of SOD, CAT, and GPx activity, as well as increase of 539 
lipid peroxidation and protein carbonylation occurred with NSAIDs in isolated form and at higher 540 
extend when NSAIDs where in binary mixtures.  541 
 542 
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6. Conclusions and future needs 543 
The exposure to the most common NSAIDs found in the aquatic ecosystems, namely acetylsalicylic 544 
acid, diclofenac, ibuprofen, naproxen, paracetamol, as well as to their mixtures, might represent a 545 
risk for non-target, freshwater invertebrates. Although data from standardized tests, in terms of  546 
EC50 or LC50 from acute or chronic toxicity tests, are comparable, it is not simple to draw a scale of 547 
toxicity of NSAIDs because of some contrasting results among studies testing the toxicity of the 548 
same drug towards the same model species or the lack of information for specific drugs. However, 549 
according to EC50 values obtained on D. magna, which was the model species on which all the 550 
NSAIDs were tested, DCF and IBU can be identified as the more toxic drugs, followed by PCM, 551 
NPX and ASA. Simultaneously, although different responses occurred within phylogenetic-related 552 
species, cladocerans can be indicated as the more sensitive organisms to NSAID exposure. 553 
Although acute toxicity of NSAIDs occurs only at high, unrealistic concentrations, much higher 554 
than those currently measured in freshwaters worldwide, sub-lethal effects due to long-term 555 
exposures cannot be neglected. A growing number of studies performed on diverse invertebrate 556 
species belonging to different levels of the ecological hierarchy showed that the exposure to low, 557 
environmentally relevant concentrations of NSAIDs, both independently and in mixture, can cause 558 
a variety of adverse effects at molecular, biochemical and cellular level, while effects at individual 559 
level (e.g., growth, survival, reproduction) seem to be less probable, although they cannot be 560 
underestimated considering that are used for risk assessment. For instance, concentrations of PCM 561 
similar to those measured in environments worldwide induced ecologically relevant effects on two 562 
species belonging to Cnidaria and Mollusca taxa (i.e., Hydra vulgaris and Corbicula fluminea, 563 
respectively). Despite these alarming findings, it is important to bearing in mind that chronic 564 
toxicity data, in term of sub-lethal effects at individual or sub-individual levels, come from two 565 
different approaches, the first one performed on whole animals exposed in vivo and the second one 566 
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on single cells isolated or collected by animals and then exposed in vitro to NSAIDs. These 567 
approaches result in different outcomes, which can lead to different considerations concerning the 568 
toxicity of NSAIDs towards aquatic organisms. For instance, EC50 or IC50 from whole animal 569 
experiments support the conclusion that NSAIDs in the environment are at much lower 570 
concentrations than those causing toxicity, while biochemical or molecular investigations from both 571 
in vitro and in vivo studies pointed out a potential hazard of these drugs also at environmentally 572 
relevant concentrations. However, some caveats need to be considered, mainly related to the 573 
uncertainty of the real amount of xenobiotic reaching the cells, the realism of exposures and the 574 
lack of cells mechanisms owned by cells to mitigate the effects of xenobiotics, as instead the whole 575 
organism have, that might result in a potential overestimation of the effect. In addition, although 576 
NSAIDs-induced molecular or biochemical effects were induced in whole body or tissues/organs 577 
isolated after in vivo exposures, they are early, and often specific, responses that the organism 578 
activate as a consequence of an exposure to these drugs. To date, there is a dearth of information 579 
concerning the effects at cellular and tissue levels induced by NSAIDs in freshwater species, 580 
including invertebrates, as well as on the propagation of the effects from the lowest levels of the 581 
biological organization to the highest ones. Moreover, sub-lethal effects highlighted by short- and 582 
mid-term exposures might be also more worrisome considering that in natural ecosystems, 583 
invertebrates are exposed to measurable NSAID concentrations for their whole lifespan. For all the 584 
reasons mentioned above, the assessment of the risk of NSAIDs towards aquatic species comparing 585 
acute or sub-lethal effects only could not be accurate. Thus, an approach using measured 586 
environmental concentrations (MECs) combined with predicted no effect concentrations (PNECs) 587 
was proposed by European commission (2003) to screen compounds with potential environmental 588 
risks and it was recently refined to properly identify the priority pollutants that should be regularly 589 
monitored in surface waters (Zhou et al., 2019). According to this approach, DCF and IBU were 590 
prioritized as high risk pharmaceuticals, PCM as moderate risk one (Zhou et al., 2019; Palma et al., 591 
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2020), while ASA as a negligible risk compound (Gómez-Canela et al., 2019). To date, the 592 
environmental risk of NPX and NSAID mixture was not assessed. This approach is crucial 593 
considering that the increasing production and use of NSAIDs worldwide might result in a notable 594 
increase in their environmental levels occurring in aquatic ecosystems, with a consequent 595 
enhancement of the risk related to the exposure to these pharmaceuticals towards non-target, 596 
freshwater invertebrates. For these reasons, further studies should be needed to enlarge the 597 
knowledge on NSAID toxicity towards aquatic organisms, not only invertebrates but also 598 
vertebrates, considering long-term exposures and the use of alternative and innovative assays to 599 
shed light on the mechanism(s) of action of these pharmaceutical compounds. Moreover, as the 600 
most of the studies on NSAID toxicity were performed on native, parental compounds, exploring 601 
the toxicity of NSAID metabolites, which might results also more toxic than the parental ones (e.g., 602 
Marques et al., 2004b; Isidori et al., 2005), should contribute to understand the hazard of these 603 
drugs. Lastly, considering that NSAIDs occur in aquatic ecosystems in complex ‘cocktails’ and few 604 
previous studies demonstrated that NSAID mixtures induced higher effects than the single 605 
compounds, further studies aimed at investigating the toxicity of binary or complex NSAID 606 
mixtures should be a priority to shed light on adverse effects, mechanism(s) of action and ecological 607 
risk of these therapeutics towards freshwater communities.  608 
 609 
 610 
 611 
 612 
 613 
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Figure and Table captions 866 
Figure 1: Studies investigating acute (panel a) or chronic (panel b) toxicity of acetylsalicylic acid 867 
(ASA), paracetamol (PCM), diclofenac (DCF), ibuprofen (IBU), naproxen (NPX) and NSAID mixture 868 
(Mixture) towards different freshwater invertebrates. 869 
Table 1: main physico-chemical properties of the investigated Non-steroidal anti-inflammatory 870 
drugs (NSAIDs). 871 
Table 2: List of studies investigating the adverse effects induced by acetylsalicylic acid (ASA) exposure 872 
towards freshwater invertebrates. Test species, range of ASA concentrations used, duration of the exposure 873 
and investigated endpoints are reported. 874 
Table 3: List of studies investigating the adverse effects induced by paracetamol (PCM) exposure towards 875 
freshwater invertebrates. Test species, range of PCM concentrations used, duration of the exposure and 876 
investigated endpoints are reported. 877 
Table 4: List of studies investigating the adverse effects induced by diclofenac (DCF) exposure towards 878 
freshwater invertebrates. Test species, range of DCF concentrations used, duration of the exposure and 879 
investigated endpoints are reported. 880 
Table 5: List of studies investigating the adverse effects induced by ibuprofen (IBU) exposure towards 881 
freshwater invertebrates. Test species, range of IBU concentrations used, duration of the exposure and 882 
investigated endpoints are reported. 883 
Table 6: List of studies investigating the adverse effects induced by Naproxen (NPX) exposure towards 884 
freshwater invertebrates. Test species, range of NAP concentrations used, duration of the exposure and 885 
investigated endpoints are reported. 886 
Table 7: List of studies investigating the adverse effects induced by the exposure to complex mixtures of 887 
NSAIDs towards freshwater invertebrates. Test species, range of concentrations of NSAIDs included in the 888 
mixture, duration of the exposure and investigated endpoints are reported. 889 
